Triclabendazole
Product Specifications
UNSPSC Description
Triclabendazole is an orally active parasite inhibitor. Triclabendazole has anti-Leishmania activity and induces gasdermin E (GSDME)-dependent pyroptosis by caspase-3 activation. Triclabendazole can be used for the research of fasciola hepatica[1][2][3].
Target Antigen
Bcl-2 Family; Caspase; Parasite; PARP; Pyroptosis
Type
Reference compound
Related Pathways
Anti-infection;Apoptosis;Cell Cycle/DNA Damage;Epigenetics;Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/triclabendazole.html
Purity
98.72
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CSC1=NC2=CC(OC3=CC=CC(Cl)=C3Cl)=C(Cl)C=C2N1
Molecular Weight
359.66
References & Citations
[1]Yan L, et al. Triclabendazole induces pyroptosis by activating caspase-3 to cleave GSDME in breast cancer cells [J]. Frontiers in Pharmacology, 2021, 12: 670081.|[2]Devine C, et al. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole [J]. Veterinary parasitology, 2012, 184(1): 37-47.|[3]Borges B S, et al. In vitro anti-Leishmania activity of triclabendazole and its synergic effect with amphotericin B [J]. Frontiers in Cellular and Infection Microbiology, 2023, 12: 1044665.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B0621/Triclabendazole-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B0621/Triclabendazole-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
68786-66-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP38227_T100-HRP 100 µL
SNAPC1 Antibody - C-terminal region: HRP (ARP38227_T100-HRP)
Ask
View Details